- Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Mitochondrially targeted α-tocopheryl succinate is antiangiogenic: potential benefit against tumor angiogenesis but caution against wound healing2011 | Central Library of Charles University
- Tubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases2013 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial2014 | Second Faculty of Medicine
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen2012 | Second Faculty of Medicine
- Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial2018 | Publication without faculty affiliation